摘要
目的研究磷脂酰肌醇3-激酶γ(PI3Kγ)小分子抑制剂AS605240对异丙肾上腺素(isoproterenol,ISO)诱导大鼠心肌肥厚和纤维化的治疗作用,并初步探讨其作用机制。方法健康雄性Wistar大鼠30只,随机分为3组(n=10),分别为ISO模型组、AS605240治疗组和正常对照组(空白组)。ISO模型组、AS605240治疗组皮下注射ISO 10 mg/(kg.d)×3 d,再5 mg/(kg·d)×11 d,复制大鼠心肌肥厚和纤维化模型,空白组注射相同体积的生理盐水;建模第2 d,AS605240治疗组给予AS605240 50 mg/(kg·d),ISO模型组和空白组给予等体积0.5%羧甲基纤维素,共给药14 d。末次给药后24 h,称取大鼠心脏质量和体质重,心脏HE染色观察组织学改变并评分,测量大鼠心重指数(HW/BW)、心功能、胶原容积分数(CVF)等。结果与正常对照组相比,ISO模型组大鼠HW/BW增加(P<0.05),心肌细胞间有大量胶原增生,心功能降低,胶原蛋白含量增加(P<0.05)。与ISO模型组大鼠相比,AS605240治疗组大鼠HW/BW降低(P<0.05),心功能有明显改善,心肌细胞间胶原沉积减少(P<0.05)。结论 AS605240对ISO引起的大鼠心肌纤维化具有一定的改善作用。
Objective To investigate the therapeutic effect of PI3Kγ inhibitor AS605240 on cardiac hypertrophy and cardiac fibrosis induced by Isoproterenol in rats.Methods Wistar rats were randomly divided into three groups(n=10),control group,ISO group(vehicle group) and AS605240 group.The rats in control group without any treatment.The rats in ISO and AS605240 group were given ISO 10 mg/kg for 3 days and 5 mg/kg for another 11 days by subcutaneous injection to prepare the animal model of cardiac fibrosis.Rats in AS605240 group were given AS605240 50 mg/(kg·d) by intraperitoneal injection continuously for 14 days.The vehicle group received the intraperitoneal injection of an equal volume of 0.5% carboxymethylcellulose.Twenty-four hours after the last treatment,rats were sacrificed.Heart,body weight,cardiac function and the CVF were measured.Results Compared with the control group,the HW/BW of ISO group was increased significantly(P0.05) with a increased collagen inter cardiac muscle cells(P0.05).Compared with ISO group, histological examination of the heart showed that AS605240 significantly relieved the rat cardiac fibrosis and reduced heart/body weight ratios in experimental cardiac fibrosis(P0.05).Conclsuion AS605240 may be an effective antagonist for cardiac hypertrophy and cardiac fibrosis.
出处
《四川大学学报(医学版)》
CAS
CSCD
北大核心
2011年第4期471-474,共4页
Journal of Sichuan University(Medical Sciences)
基金
国家"重大新药创制"科技重大专项项目(项目编号2009ZX09102-045)
教育部留学回国人员科研启动基金(项目编号JS20081007506765)资助